Overview

Avexitide Safety and Efficacy to Treat Acquired Hyperinsulinemic Hypoglycemia

Status:
Recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
The primary goal of this study is to evaluate the safety and efficacy of two different dosing regimens of an investigational drug called Avexitide in treating low blood sugar in patients with Acquired Hyperinsulinemic Hypoglycemia.
Phase:
Phase 2
Details
Lead Sponsor:
Dr. Tracey McLaughlin, MD
Collaborator:
Eiger BioPharmaceuticals